Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Oktober 2016 07:30 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Presents Data on STING Agonist SB 11285 at the AACR Special Conference on Tumor Immunology and Immunotherapy

HOPKINTON, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
13. Oktober 2016 07:30 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals to Present at Dawson James Securities 2016 Stock Growth Conference

HOPKINTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
06. September 2016 16:05 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Abstracts on STING Agonist SB 11285 Accepted for Poster Presentations at AACR Special Conference on Tumor Immunology and Immunotherapy

HOPKINTON, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
22. August 2016 17:00 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals, Inc. to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 13th, 2016

HOPKINTON, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
01. August 2016 17:14 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Announces Second Quarter 2016 Financial Results and Recent Highlights

HOPKINTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
28. Juli 2016 16:05 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors

MILFORD, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
27. Juni 2016 08:00 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Added to Russell Microcap® Index

HOPKINTON, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
22. Juni 2016 08:00 ET | Quelle: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Doses the First Patient in the ACHIEVE Global Phase 2 Program of SB 9200 in Hepatitis B (HBV)

HOPKINTON, Mass., June 22, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
25. Mai 2016 08:00 ET | Quelle: Spring Bank Pharmaceuticals, Inc.

Spring Bank Pharmaceuticals to Present at Upcoming Investor Conferences

MILFORD, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
11. Mai 2016 14:17 ET | Quelle: Spring Bank Pharmaceuticals, Inc.

Spring Bank Pharmaceuticals Announces Closing of Initial Public Offering

MILFORD, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral...

Vorherige Seite

Nächste Seite